메뉴바로가기
메인메뉴 바로가기
컨텐츠 바로가기
Huons
Humedix
HuM&C
Huons Biopharma
Huons meditech
Huonslab
Food Assemble
Huons USA
Huons JAPAN
Huons LifeSciences
Huons N
Pangen Biotech
주메뉴
Introduction
Founder
President
Greeting
Management
Philosophy
History
Company
Identity
Direction
Group Introduction
Current Status
Company
Introduction
News
Investment Information
Stock
Information
Disclosure
Information
Financial
Information
IR NEWS
Customer Service
Q&A
Information
for Inquiry
언어선택
KOR
ENG
메인비쥬얼
Investment Information
메인 컨텐츠
메인바로가기
Investment Information
Introduction
Group Introduction
Investment Information
Customer Service
Financial Information
Stock Information
Disclosure Information
Financial Information
IR NEWS
Financial Information
Consolidated Financial Statements
Sortation
2024
2023
2022
Current assets
572,346
591,196
611,226
Non-current assets
833,603
726,769
631,883
Total Assets
1,405,949
1,317,964
1,243,109
Current liabilities
302,466
301,140
367,562
Non-current liabilities
139,318
106,148
89,671
Total Liabilities
441,784
407,287
457,234
Dominant business owner's equity
520,109
501,825
464,316
Non-controlling interests
444,056
408,852
321,559
Total Equity
964,165
910,677
785,876
Consolidated Income Statements
Sortation
2024
2023
2022
Revenue
813,461
758,380
664,365
Operating Income
96,991
113,950
86,476
Profit(loss) before tax
90,364
119,633
655
Net income
67,127
92,628
-33,463
Separate Financial Statements
Sortation
2024
2023
2022
Current assets
24,548
50,455
84,321
Non-current assets
452,361
442,621
440,571
Total Assets
476,909
493,076
524,892
Current liabilities
95,398
110,363
156,099
Non-current liabilities
16,907
14,599
4,294
Total Liabilities
112,305
124,962
160,393
Total Equity
364,604
368,114
364,499
Separate Income Statements
Sortation
2024
2023
2022
Revenue
40,035
39,328
32,931
Operating Income
14,616
11,066
11,090
Profit(loss) before tax
5,567
17,436
6,785
Net income
4,404
12,541
4,175